Table 1.

Comparison of expression levels of MORC2 with clinicopathological features in 210 patients with gastric cancer tissues

	No.	MORC2 folda	P-value*
Age (years)
≥65	82	2.60 (2.00–2.85)	0.389
<65	128	2.45 (2.00–2.75)
Sex
Male	158	2.55 (2.00–2.80)	0.103
Female	52	2.35 (1.85–2.75)
Tumor size (cm)
≥4	136	2.65 (2.10–2.80)	0.020
<4	74	2.35 (1.85–2.75)
Histological grade
Low	59	2.35 (1.85–2.75)	0.042
High	151	2.55 (2.00–2.80)
Macroscopic type
Early stage	30	2.25 (2.00–2.70)	0.382
Borrmann I + II	16	2.70 (2.00–2.825)
Borrmann III + IV	164	2.55 (2.00–2.80)
Depth of invasion (pT)
T1 + T2	171	2.45 (1.90–2.75)	0.002
T3 + T4	39	2.70 (2.55–2.85)
Lymph node status (pN)
N0 + N1	148	2.375 (1.90–2.80)	0.09
N2 + N3	62	2.65 (2.20–2.80)
Distant metastasis (pM)
No	197	2.45 (2.00–2.75)	0.005
Yes	13	2.85 (2.65–2.85)
Pathological stage (pTNM stage)
Stage I + II	112	2.35 (1.95–2.75)	0.021
Stage III + IV	98	2.65 (2.10–2.80)

*Indicated statistical significance (P < 0.05)

^aMedian of relative expression, with 25th–75th percentile in parenthesis